You’re on our free tier. Upgrade to NewsNow Essentials now and get your favourite news platform, faster, slicker and ads free.You’re on our free tier. Upgrade to NewsNow Essentials now. Faster, slicker and ads free.You’re on our free tier. Upgrade and go ads free now!

Home
Hot Topics
Nigeria
Politics
Crime
Premier League
Economy
Africa
World
Entertainment
Sport
La Liga
Serie A
Bundesliga
Lifestyle
Bitcoin
Cryptocurrencies
Sensational News

Regeneron
Health & Fitness
Disability
Diabetes
Cancer
Diet and Fitness
Rare Diseases
Antibiotic Resistance
Alopecia
Heart Disease
Mental Health
Reproductive Health
Obesity
Topics

Advertisement

Regeneron

Share

Top Latest Popular

Regeneron's Applications for gMG Drug Accepted by FDA and EMA Zacks 6d

Zacks 6d

European Medicines Agency

Regeneron’s New Drug Application for cemdisiran accepted for review by FDA and EMA PMLiVE 7d

PMLiVE 7d

European Medicines Agency The Lancet

This little-known biotech just delivered a bigger IPO pop than SpaceX -- and Regeneron is already invested The Motley Fool 2d

The Motley Fool 2d

SpaceX Biotechnology

Advertisement

2 Underrated weight loss stocks to buy and hold The Motley Fool 6d

The Motley Fool 6d

Tirzepatide Amycretin

Advertisement

Advertisement

Latest

Yesterday

This Little-Known Biotech Just Delivered a Bigger IPO Pop Than SpaceX -- and Regeneron Is Already Invested The Motley Fool 01:32 Sun, 28 Jun

Friday

How Investors May Respond To Regeneron Pharmaceuticals (REGN) Cemdisiran Priority Review for gMG Treatment Simply Wall St 20:53 Fri, 26 Jun

Thursday

Regeneron to Report Second Quarter 2026 Financial and Operating Results and Host Conference Call and Webcast Regeneron Pharmaceuticals (Press Release) 21:12 Thu, 25 Jun

Tuesday

Regeneron's Applications for gMG Drug Accepted by FDA and EMA Zacks 20:32 Tue, 23 Jun

2 Underrated Weight Loss Stocks to Buy and Hold The Motley Fool 07:55 Tue, 23 Jun

In the last month

Regeneron’s New Drug Application for cemdisiran accepted for review by FDA and EMA PMLiVE 12:32 Mon, 22 Jun

Cemdisiran Regulatory Submissions Accepted for Review by FDA and EMA for the Treatment of Generalized Myasthenia Gravis (gMG) Regeneron Pharmaceuticals (Press Release) 12:01 Mon, 22 Jun

Regeneron (REGN) Stock Valuation After WHO Ebola Trial Backing And Expanding R&D Collaborations Simply Wall St 10:20 Sat, 13 Jun

Regn Investors Have Opportunity to Join Regeneron Pharmaceuticals, Inc. Fraud Investigation with the Schall Law Firm Business Wire (Press Release) 20:09 Wed, 10 Jun

How WHO’s Maftivimab Priority for Bundibugyo Trials At Regeneron Pharmaceuticals (REGN) Has Changed Its Investment Story Simply Wall St 10:26 Wed, 10 Jun

Advertisement

Advertisement

Advertisement

Regeneron News

Latest news and updates on Regeneron Pharmaceuticals, an American biotechnology company that was founded in 1988. The company is listed on NASDAQ.

NewsNow

Our Sites

NewsNow Nigeria

NewsNow România

NewsNow Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Back to Lifestyle Health & Fitness
- Diet and Fitness
- Mental Health
- Cancer Cancer
- Diabetes Diabetes
- Disability Disability
- Gastrointestinal Diseases
- Infectious Diseases
- Neurological Diseases
- Reproductive Health
- Sexual Health
- Allergies Allergies
- Alopecia Alopecia
- Antibiotic Resistance
- Assisted Dying
- Blood Disorders
- Heart Disease
- Obesity Obesity
- PTSD PTSD
- Rare Diseases
- SIDS SIDS